🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
This is an open-label, multicenter, extension study. Patients who are recei...
Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Start Date
2019-02-28
Trial ID
NCT03768063
This is a prospective non-randomized national clinical phase 2 trial that a...
Status
Recruiting
Location
Turku University Hospital Cancer Centre
Start Date
2021-12-10
Trial ID
NCT05159245
This multicenter, non-randomized, open-label study will evaluate the effica...
Status
Completed
Location
Western Regional Medical Center at Cancer Treatment Centers of America
Start Date
2014-04-14
Trial ID
NCT02091141
Treatments Being Tested
Evaluation of the efficacy, safety and biologic effects of neo-adjuvant tre...
Status
Terminated
Location
Department of Dermatology & Skin Cancer University Hospital La Timone, Aix-Marseille University
Start Date
2015-01-22
Trial ID
NCT02303951
Treatments Being Tested
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested
The purpose of this study is to determine wether cobimetinib + vemurafenib ...
Status
Completed
Location
CHU de Bordeaux
Start Date
2015-12
Trial ID
NCT02537600
Treatments Being Tested
This phase II trial studies how well atezolizumab in combination with chemo...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-07-27
Trial ID
NCT03181100
Treatments Being Tested
To evaluate the efficacy of vemurafenib in combination with cobimetinib (GD...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-01-08
Trial ID
NCT01689519
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested